_how-are-targeted-therapy-and-immunotherapy-used-in-lung-cancer-care.jpg "How Are Targeted Therapy and Immunotherapy Used in Lung Cancer Care? from immunotherapy in cancer Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 3 min 8 sec
✓ Published: 20-Oct-2021
✓ Published: 20-Oct-2021
Description:
Expert Dr. Heather Wakelee explains how targeted therapy and immunotherapy work to treat lung cancer and which patient type each therapy is most appropriate for.nnDr. Heather Wakelee is a thoracic medical oncologist deputy director of the Stanford Cancer Institute where she also serves as the division chief of medical oncology. Learn more about Dr. Wakelee, here: https://stanfordhealthcare.org/doctors/w/heather-wakelee.html.
Expert Dr. Heather Wakelee explains how targeted therapy and immunotherapy work to treat lung cancer and which patient type each therapy is most appropriate for.nnDr. Heather Wakelee is a thoracic medical oncologist deputy director of the Stanford Cancer Institute where she also serves as the division chief of medical oncology. Learn more about Dr. Wakelee, here: https://stanfordhealthcare.org/doctors/w/heather-wakelee.html.
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_immunotherapy-in-cancer-treatment-124-best-explained-by-dr-ishu-gupta.webp "Vaidam")
_d1-1600-t2-howard-mcleod-moffitt-cancer-center.webp "Day 1 Track 2 Session: Total Cost Challenges of IO Care nnImmunotherapy is quickly establishing itself as a key treatment paradigm in cancer and is already changing the standard of care for some indications. Respective drugs have already been approved for melanoma, non–small cell lung cancer (NSCLC), and renal cell carcinoma.With the promise of a cure in a growing list of indications, these drugs also come with a high cost further fueling the ongoing debate on how to control healthcare costs w")
_immunotherapy-treatments-for-non-small-cell-lung-cancer-nsclc.webp "You and Lung Cancer")
_cancer-disappears-in-all-patients-during-immunotherapy-drug-trial.webp "TODAY")
_cancer-immunotherapy-101-with-dr-e-john-wherry.webp "Cancer Research Institute")
_cutting-edge-immunotherapy-treatment-removes-all-traces-of-cancer-in-woman.webp "CBS News")
⏲ 7 minutes 35 seconds 👁 28K
_tracey-l-evans-md-on-nsclc-combined-modality-therapy.webp "Tracey L. Evans, MD, of the University of Pennsylvania, discusses the data supporting use of chemotherapy with radiation in locally advanced non–small cell lung cancer, targeted treatments and immunotherapy, and some of the controversies now debated.")
_david-g-maloney-md-phd-on-all-new-therapeutic-agents.webp "David G. Maloney, MD, PhD, of the Fred Hutchinson Cancer Research Center, reviews the clinical data and ongoing trials evaluating immunotherapy in the setting of relapsed or refractory acute lymphocytic leukemia and discusses major adverse events of treatment.")
_immunotherapy-in-cancer-treatment-124-best-explained-by-dr-ishu-gupta.jpg)
_d1-1600-t2-howard-mcleod-moffitt-cancer-center.jpg)
_immunotherapy-treatments-for-non-small-cell-lung-cancer-nsclc.jpg)
_cancer-disappears-in-all-patients-during-immunotherapy-drug-trial.jpg)
_cancer-immunotherapy-101-with-dr-e-john-wherry.jpg)
_cutting-edge-immunotherapy-treatment-removes-all-traces-of-cancer-in-woman.jpg)
_tracey-l-evans-md-on-nsclc-combined-modality-therapy.jpg)
_david-g-maloney-md-phd-on-all-new-therapeutic-agents.jpg)
![[+]](/images/menu.gif){kind=small}